EyePoint Pharmaceuticals Inc. buy Mizuho
Start price
07.12.23
/
50%
€19.70
Target price
07.12.24
€27.74
Performance (%)
-57.08%
Price
04.06.24
€8.46
Summary
This prediction is currently active. The BUY prediction by Mizuho for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -57.08%. This prediction currently runs until 07.12.24. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | -16.690% | -16.690% |
iShares Core DAX® | -1.042% | 2.220% |
iShares Nasdaq 100 | -1.361% | 3.207% |
iShares Nikkei 225® | -0.044% | -1.680% |
iShares S&P 500 | -0.480% | 2.165% |
Comments by Mizuho for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target raised by analysts at Mizuho from $20.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Mizuho for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
-14.72%
04.06.24
04.06.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.60
17.02.24
17.02.24
€36.18
17.02.25
17.02.25
-68.21%
04.06.24
04.06.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.00
02.11.23
02.11.23
€18.78
02.11.24
02.11.24
20.80%
04.06.24
04.06.24